Molecular analysis of altered intracellular dopamine pools in substantia nigra
黑质细胞内多巴胺库改变的分子分析
基本信息
- 批准号:6259642
- 负责人:
- 金额:$ 22.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-30 至 2004-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
While the pathogenesis of idiopathic Parkinson's Disease remains enigmatic, there is considerable evidence associating the cognition with heightened oxidative stress. Although the agent(s) responsible has not been elucidated, a plausible candidate is dopamine itself, which readily oxidizes to produce quinones and other free radicals, and is more toxic to cultured neurons than similar concentrations of MPTP. Toxic oxyradical dopamine metabolites may attack essential cytosolic proteins, providing a signal that renders them subject to ubiquitin-mediated proteolysis and degradation. Ubiquitin-positive Lewy bodies are the characteristic cellular hallmarks of Parkinson's Disease and it is thought by some that these inclusions result from an accumulation of abnormal proteins, prominently including neurofilament proteins as well as alpha-synuclein and cdk5. It is therefore possible that aberrant dopamine oxidative metabolism not only contributes to the selective degeneration of substantia nigra neurons but also to formation of Lewy bodies, as well as playing a well-established role in neuromelanin formation in lysosomal/endosomal compartments. In this proposal, we outline experiments designed to test how aberrations in vesicular and cytosolic dopamine pools initiate degeneration of substantia nigra neurons in postnatally-derived cultures. We will use four tools to alter substantia nigra intracellular dopamine. 1) Substantia nigra cultures derived from VMAT2 knockout mice, which are unable to sequester dopamine in synaptic vesicles. 2) Methamphetamine, which redistributes dopamine from synaptic vesicles to the cytosol, increasing the cytosolic pool and the transmitter available for release and eventually results in oxyradical-mediated synaptic degeneration. 3) L-DOPA, which is rapidly converted to cytosolic dopamine, resulting in an elevated vesicular dopamine pool and quantal size (the number of molecules released per synaptic vesicle exocytosis). We will also use neuronal cultures derived from alpha-synuclein knockout mice to determine if this protein is involved in biosynthesis of neuromelanin and ubiquitin inclusions. Remarkably, these approaches can be used to induce formation of intracellular neuromelanin and intracellular ubiquitinated inclusions, providing the first in vitro system for study of these features. These studies promise to provide information on neurodegeneration and the cell biology related to Parkinson's Disease in a preparation that provides the opportunity to study interventions in a living, malleable system.
虽然特发性帕金森病的发病机制仍然是谜,但有相当多的证据表明认知与氧化应激升高有关。虽然尚未阐明起作用的因素,但一个可能的候选因素是多巴胺本身,它很容易氧化产生醌和其他自由基,对培养的神经元的毒性比类似浓度的MPTP更大。有毒的氧自由基多巴胺代谢物可能攻击必需的细胞质蛋白,提供一个信号,使它们受到泛素介导的蛋白水解和降解。泛素阳性的路易小体是帕金森病的特征性细胞标志,一些人认为这些包涵体是由异常蛋白的积累引起的,主要包括神经丝蛋白、α -突触核蛋白和cdk5。因此,异常的多巴胺氧化代谢不仅可能导致黑质神经元的选择性变性,还可能导致路易小体的形成,并在溶酶体/内体区室的神经黑色素形成中发挥着既定的作用。在这一建议中,我们概述了旨在测试在后天培养中,囊泡和胞质多巴胺池的畸变如何引发黑质神经元的变性的实验。我们将使用四种工具来改变黑质细胞内多巴胺。1)来自VMAT2基因敲除小鼠的黑质培养物,这些小鼠无法在突触囊泡中隔离多巴胺。2)甲基苯丙胺,将多巴胺从突触囊泡重新分配到胞质中,增加胞质池和可释放的递质,最终导致氧化自由基介导的突触变性。3) L-DOPA,迅速转化为胞质多巴胺,导致囊泡多巴胺池和量子大小(每个突触囊泡胞吐释放的分子数量)升高。我们还将使用来自α -突触核蛋白敲除小鼠的神经元培养物来确定该蛋白是否参与神经黑色素和泛素包涵体的生物合成。值得注意的是,这些方法可用于诱导细胞内神经黑色素和细胞内泛素化包裹体的形成,为研究这些特征提供了第一个体外系统。这些研究有望提供与帕金森氏病相关的神经变性和细胞生物学信息,为研究活的、可塑的系统中的干预措施提供机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Sulzer其他文献
David Sulzer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Sulzer', 18)}}的其他基金
2015 Parkinson's Disease Gordon Research Conference
2015年帕金森病戈登研究会议
- 批准号:
8835619 - 财政年份:2014
- 资助金额:
$ 22.58万 - 项目类别:
ROLES FOR ALPHA-SYNUCLEIN DEGRADATION AND CYTOSOLIC DOPAMINE IN PD PATHOGENESIS
α-突触核蛋白降解和胞质多巴胺在 PD 发病机制中的作用
- 批准号:
8411745 - 财政年份:2012
- 资助金额:
$ 22.58万 - 项目类别:
Presynaptic Plasticity of Vesicular Dopamine Release
囊泡多巴胺释放的突触前可塑性
- 批准号:
7513682 - 财政年份:2007
- 资助金额:
$ 22.58万 - 项目类别:
PRESYNAPTIC PLASTICITY OF VESICULAR DOPAMINE RELEASE
囊泡多巴胺释放的突触前可塑性
- 批准号:
7088089 - 财政年份:2006
- 资助金额:
$ 22.58万 - 项目类别:
Basic Neuroscience Training Grant at Columbia University
哥伦比亚大学基础神经科学培训补助金
- 批准号:
6749766 - 财政年份:2004
- 资助金额:
$ 22.58万 - 项目类别:
Basic Neuroscience Training Grant at Columbia University
哥伦比亚大学基础神经科学培训补助金
- 批准号:
7869590 - 财政年份:2004
- 资助金额:
$ 22.58万 - 项目类别:
相似海外基金
Inhibition of cell-to-cell propagation of alpha-synuclein aggregation by glial cells and its involvement in neuropathology in Parkinson's disease.
神经胶质细胞抑制α-突触核蛋白聚集的细胞间传播及其参与帕金森病的神经病理学。
- 批准号:
23K06928 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ordering the disordered in Parkinson's disease to derive peptide inhibitors of alpha-synuclein toxicity
命令帕金森病患者衍生出α-突触核蛋白毒性的肽抑制剂
- 批准号:
2884235 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Studentship
Alpha-Synuclein-Specific T cells in Parkinson's Disease Pathogenesis
帕金森病发病机制中的α-突触核蛋白特异性 T 细胞
- 批准号:
10752172 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins
研究帕金森病蛋白 α-突触核蛋白和 RNA 结合蛋白之间的生理和病理生理联系
- 批准号:
10744556 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Ordering the disordered in Parkinson's disease to derive peptide inhibitors of alpha-synuclein toxicity
命令帕金森病患者衍生出α-突触核蛋白毒性的肽抑制剂
- 批准号:
2892099 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Studentship
Elucidation of alpha-synuclein aggregation mechanism in Parkinson's disease and application to novel therapeutic strategies
帕金森病中α-突触核蛋白聚集机制的阐明及其在新治疗策略中的应用
- 批准号:
23K06828 - 财政年份:2023
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interactions of alpha-synuclein with lipid membranes and their relation to the Parkinson's Disease
α-突触核蛋白与脂质膜的相互作用及其与帕金森病的关系
- 批准号:
571741-2022 - 财政年份:2022
- 资助金额:
$ 22.58万 - 项目类别:
University Undergraduate Student Research Awards
Inactivation mechanism of alpha-synuclein oligomer toxicity in Parkinson's disease
帕金森病中α-突触核蛋白寡聚体毒性的灭活机制
- 批准号:
22K15377 - 财政年份:2022
- 资助金额:
$ 22.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Differentiation and characterization of conformational alpha-synuclein strains associated with Parkinson's disease and related synucleinopathies
与帕金森病和相关突触核蛋白病相关的构象α-突触核蛋白菌株的分化和表征
- 批准号:
10460906 - 财政年份:2021
- 资助金额:
$ 22.58万 - 项目类别:
Alpha-synuclein driven cellular changes and vocal dysfunction in Parkinson's Disease
帕金森病中α-突触核蛋白驱动的细胞变化和发声功能障碍
- 批准号:
10283440 - 财政年份:2021
- 资助金额:
$ 22.58万 - 项目类别: